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The Efficacy of Metallic Stent Placement
in the Treatment of Colorectal
Obstruction
Objective: To evaluate the efficacy of newly designed covered and non-cov-
ered coated colorectal stents for colonic decompression.
Materials and Methods: Twenty-six patients, (15 palliative cases and 11 pre-
operative) underwent treatment for the relief of colorectal obstruction using metal-
lic stents positioned under fluoroscopic guidance. In 24 of the 26, primary col-
orectal carcinoma was diagnosed, and in the remaining two, recurrent colorectal
carcinoma. Twenty-one patients were randomly selected to receive either a type
A or type B stent; for the remaining five, type C was used. Type A, an uncovered
nitinol wire stent, was lightly coated to ensure structural integrity. Type B (flare
type) and C (shoulder type) stents were polyurethane covered and their diameter
was 24 and 26mm, respectively. The rates of technical success, clinical success,
and complications were analyzed using the chi-square test, and to analyse the
mean period of patency, the Kaplan-Meier method was used.
Results: Thirty of 31 attempted placements in 26 patients were successful,
with a technical success rate of 96.8% (30/31) and a clinical success rate of
80.0% (24/30). After clinically successful stent placement, bowel decompression
occurred within 1 4 (mean, 1.58 0.9) days. Five of six clinical failures involved
stent migration and one stent did not expand after successful placement. In the
preoperative group, 11 stents, one of which migrated, were placed in ten patients,
in all of whom bowel preparation was successful. In the palliative group, 19 stents
were placed in 15 patients. The mean period of patency was 96.25 105.12
days: 146.25 112.93 for type-A, 78.82 112.26 for type-B, and 94.25 84.21
for type-C. Complications associated with this procedure were migration (n=6,
20%), pain (n=4, 13.3%), minor bleeding (n=5, 16.7%), incomplete expansion
(n=1, 3.3%), and tumor ingrowth (n=1, 3.3%). The migration rate was significantly
higher in the type-B group than in other groups (p=0.038).
Conclusion: Newly designed covered and non-covered metallic stents of a
larger diameter are effective for the treatment of colorectal obstruction. The
migration rate of covered stents with flaring is higher than that of other types. For
evaluation of the ideal stent configuration for the relief of colorectal obstruction, a
clinical study involving a larger patient group is warranted.
n advanced colorectal cancer, obstruction is a common complication, par-
ticularly if the lesion is located in the left colon (1 5). In recent years,
some authors have reported favorable results of the nonsurgical treat-
ment of colonic obstruction using an uncovered expandable metallic stent 10 22 mm
in diameter (1 12). The placement of an uncovered self-expanding metallic stent, a
minimally invasive procedure, can be performed without general anesthesia and re-
duces the need for colostomy (8). It provides temporary decompression of the colon
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Ibefore single-stage surgery, or may be used for palliation.
Patients undergoing palliative treatment have, however,
developed new colonic obstructions or tumor growth into
the stent (7), and additional complications have included
stent migration, pain, bleeding, and bowel perforation (1
12). To prevent tumor ingrowth and to treat fistulae, Choo
et al. applied a polyurethane covering to the metallic stent
but migration and problems with the introductory system
persisted (7). The purpose of this prospective study was to
implement the use of newly developed larger diameter
self-expandable covered and non-covered stents, and to
evaluate their efficacy in the treatment of colorectal ob-
structions.
MATERIALS AND METHODS
Patients
Between May 1999 and July 2000, 26 consecutive pa-
tients were treated for the relief of colorectal obstruction
via fluoroscopically guided anal intubation of expandable
metallic stents of three different types. Pre-procedural in-
formed consent was obtained from all patients. Stent place-
ment was for palliative care in 15 cases and preoperative
treatment in 11. In 24 patients the diagnosis was primary
colorectal carcinoma, and in the other two, recurrent col-
orectal carcinoma. A diagnosis of colonic obstruction was
initially established by means of the patient’s clinical histo-
ry, rectal examination, and conventional abdominal radi-
ography. To determine whether an obstructive mass was
present, and if so, its precise location, computed tomogra-
phy (CT) followed by barium-enema or water-soluble con-
trast enema examination, or both, was then performed.
Twenty-one patients were randomly selected to receive ei-
ther a type-A or type-B stent, and for the remaining five,
type C was used.
Stent Design
At the beginning of the study only two types of colorec-
tal stent, made of lightly coated wire (type A)or fully
polyurethane covered (type B), were designed and con-
structed. In order to decrease migration, type C was de-
vised later (Fig. 1). Stent length averaged 8.4 (range, 6
14) cm.
The type-A stent, 30 mm in diameter and with its ends
flared to 40mm to prevent migration, was woven from a
single thread of 0.25-mm nitinol wire in a tubular configu-
ration. It was lightly coated with a 12% polyurethane solu-
tion (Biospan; Polymer Technology Group, Emeryville,
Cal., U.S.A.), and a dipping method was used to increase
its expansile power by fixing the crossing of the wire. It
was loaded in a 4-mm introducer for deployment.
The type-B stent consisted of several 3-cm-long seg-
ments, each woven from a single thread of 0.25-mm nitinol
wire in a tubular configuration. The body of each segment
was 24 mm in diameter, with the ends flared to 34 mm. To
cover the segments, an Epolene wax mold (Eastman
Kang et al.
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Fig. 1. A. Three types of colorectal stent: type A (upper), type B (middle), and type
C (lower).
B. The drawstring. Each bend of each segment contains a 2-mm-diameter nylon
monofilament loop secured with sutures (thin arrow). These loops form the anchor
for another nylon thread which is passed through each of them to form a large
loop or drawstring (thick arrow) that fills the inner circumference of the inside of the
proximal stent. The resultant loop is then tied at the stent’s upper inner margin.
A
BChemical, Kingsport, Tenn., U.S.A.) was used. Several seg-
ments were set on its surface, and it was then dipped into
the polyurethane solution and dried in an oven for 24
hours. One hundred percent nylon mesh was used to se-
cure the segment connections.
The type-C stent, also polyurethane covered, was made
from several 2-cm-long segments knitted from a single
thread of 0.25-mm nitinol wire in a tubular configuration
and an interlocking diamond-shaped pattern. This stent
consisted of three parts: a head and a tail (both 40 mm in
diameter) and a body (26 mm in diameter). The head and
tail were connected at right angles to the body, and cov-
ered with a 12% polyurethane solution using the same
technique employed for type B. Stent types B and C were
loaded in a 7-mm introducer.
So that types B and C could be removed, a 2-mm-diame-
ter nylon monofilament loop was placed inside each bend
and secured with sutures (Fig. 1). These loops formed the
anchor for another nylon thread which was passed through
each of them to form a large loop or drawstring that filled
the inner circumference of the inside of the distal stent.
The resultant loop was then tied at the upper inner margin
of the stent.
Before use, stent hoop strength was measured to com-
pare radial force. HD25 was defined as the measured hoop
strength when a stent’s circumference was decreased to
75% of its baseline length, and as HD50 when the circum-
ference was decreased to 50%. A 10-mm-wide strip was
used to apply stress to each stent: for types A, B and C,
HD25 was 270, 460, and 150 grams force, respectively,
while for HD50, the respective readings were 530, 690,
and 280 (Table 1). 
Stent Insertion Technique
Tumor location was determined using a barium-sulfate
suspension or water-soluble contrast material. Under fluo-
roscopic guidance, a 145-cm-long, 0.038-inch-diameter hy-
drophilic guidewire (Terumo, Tokyo, Japan) was advanced
across the obstruction, allowing an angiographic catheter
to be positioned above it. The guidewire was then re-
moved, and the length and position of the obstruction were
determined by the injection of contrast material prior to
stent placement. A 0.038-inch-diameter stiff guide wire
(Amplatz Superstiff; Meditech/Boston Scientific,
Watertown, Mass., U.S.A.) was then introduced. Under
fluoroscopic guidance, the whole introductory assembly (a
sheath, a compressed stent, and a pusher catheter) was
passed over the guidewire into the rectum and advanced
until the distal tip of the stent reached approximately 2 cm
beyond its stricture. The pusher catheter was held in place
with one hand while the sheath was slowly withdrawn in a
continuous motion with the other. This freed the stent, al-
lowing it to lie within the stricture and expand. Technical
success was defined as successful placement of the stent at
the lesion site.
Follow-up
To determine the stent’s position and the relief of colonic
obstruction until the patient was discharged, a convention-
al radiograph of the abdomen was obtained and changes in
bowel gas patterns were analyzed within 24 hours of stent
placement and each subsequent day thereafter. Clinical
failure was defined as the failure of decompression (includ-
ing stent migration) after successful stent placement. If
surgery was indicated, the patient underwent elective sur-
gical resection of the tumor, with primary anastomosis of
the colon. Patients in the palliative group underwent clini-
cal follow-up, conventional abdominal radiographs being
obtained at monthly intervals. In one patient in whom a
type-A stent was placed, endoscopy was performed to
evaluate the cause of symptom recurrence. Period of pa-
tency was defined as the period from stent placement to
the recurrence of symptoms of obstruction in clinically suc-
cessful cases. The rate of technical success, clinical success
and complications were analyzed using the chi-square test,
and to analyze the mean period of patency, the Kaplan-
Meier method was used. The confidence interval was 95%.
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Table 1. Physical Properties of the Stents
Diameter Diameter
Antimigration Body
Size of
Status of Longl.
Hoop Strength
Type of Nitinol  of Stent
Design Construction
SDS
Covering
Retrieval
Flexibility
(Gram-force)
Wire(mm) (mm) (mm) 25% 50%
A 0.25 30 flaring single 4
wire surface not
good 270 530
coating available
B 0.25 24 flaring multiple 7 Pu covering available good 460 690
C 0.25 26 shoulder multiple 7
Pu covering
available good 150 280
with nylon
Note. SDS = stent delivery system, Pu = polyurethane, longl. = longitudinalKang et al.
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Table 2. Summary of 26 Patients with Colorectal Obstruction  Treated with Metallic Stents
PT
Age/
Diagnosis Indication Guide
Technical
Type (L) F/U Migration Outcome
Sex Results
#1 74/F Primary rectosigmoid Palliative F Successful B/B 6 210 Yes/Yes Obstruction relieved, obstruction 
colon ca recurred; palliative colostomy
7 months after stent migration
#2 41/M Primary rectal ca Presurgical F Successful B/B 6 009 Yes/No Successful bowel preparation
#3 43/M Primary rectal ca Palliative F Successful B/B 9 005 Yes/Yes Obstruction relief failed;
T-loop colostomy
#4 41/M Primary rectal ca Palliative F Successful B 9 008 No Obstruction relieved; patient died
#5 38/F Primary rectal ca Palliative F Successful B 9 008 No Obstruction relieved; patient died
#6 63/F Primary rectosigmoid Palliative F Successful A 12 270 No Obstruction relieved; patient died
colon ca
#7 71/M Primary descending  Palliative F Successful B 12 330 No Obstruction relieved; patient died
colon ca
#8 36/F Primary rectosigmoid Palliative F Successful B 12 180 No Obstruction relieved, obstruction
colon ca recurred; palliative ileostomy
#9 77/M Primary rectosigmoid Presurgical F Successful A 6 008 No Obstruction relieved;
colon ca successful bowel preparation
#10 69/F Primary rectosigmoid Presurgical F Successful A 6 004 No Obstruction relieved;
colon ca successful bowel preparation
#11 80/M Primary rectosigmoid Palliative F Successful B/A 9 027 Yes/ No Obstruction relieved; follow-up loss
colon ca
#12 63/M Primary rectosigmoid Presurgical F Successful A 9 005 No Obstruction relieved;
colon ca successful bowel preparation
#13 18/F Primary descending Presurgical F Successful A 7 004 No Obstruction relieved;
colon ca successful bowel preparation
#14 84/M Primary descending Palliative F Successful B 12 090 No Obstruction relieved
colon ca
#15 78/M Primary rectosigmoid Presurgical F Successful B 6 003 No Obstruction relieved;
colon ca successful bowel preparation
#16 61/F Primary rectal ca Presurgical F Successful B 5 005 No Obstruction relieved;
successful bowel preparation
#17 38/M Primary rectal ca, Presurgical F Successful B 12 002 No Obstruction relieved;
colonic polyposis successful bowel preparation
#18 64/F Primary ascending Presurgical F Failed No
colon ca
#19 87/F Primary rectosigmoid Palliative F Successful B 6 026 No Obstruction relieved; patient died
colon ca
#20 56/F Primary rectosigmoid Palliative F Successful A 8 078 No Obstruction relieved; patient died
colon ca
#21 60/F Primary descending Palliative F Successful A/C 8 210 No Obstruction relieved; patient died
colon ca
#22 73/F Primary rectal ca Presurgical F Successful C 10 006 No Obstruction relieved;
successful bowel preparation
#23 70/F Recurrent rectosigmoid Palliative F Successful C(C) 12 080 No Stent reinsertion due to malpositioning;
colon ca obstruction relieved; patient died
#24 78/M Recurrent rectosigmoid Palliative F  Successful C 6 008 No Obstruction relief failed;
colon ca T-loop colostomy
#25 50/M Primary rectal ca, Palliative F Successful C 10 079 No Obstruction relieved, obstruction
liver metastasis recurred; T-loop colostomy
#26 72/F Primary rectal ca Presurgical F Successful C 10 004 No Obstruction relieved; successful
bowel preparation
Note. PT = patient, ca = carcinoma, F = fluoroscopy, E = endoscopy, (L) = length of stent in cm, F/U = follow-up period in daysRESULTS
Thirty (8 type-A; 16 type-B; and 6 type-C stents) of 31
attempted placements in 26 patients were successful, with
a technical success rate of 96.8% (Table 2). Despite the in-
tegration of fluoroscopic and endoscopic guidance, we
were unable to advance a guidewire through the obstruct-
ed distal ascending colon in one patient (#18). The clinical
success rate was 80.0% (24/30): 100% for type A, 68.8%
for type B, and 83.3% for type C (Table 3); the differences
were statistically insignificant (p=0.191). In 24 clinically
successful stent placements, bowel obstructions were re-
solved within 1 4 (mean, 1.58 0.9) days of placement.
In six cases of clinical failure, five stents had migrated and
one did not expand after successful placement. In the 24
clinically successful instances, patients were able to defe-
cate frequently, though seven complained of abdominal
discomfort.
In the preoperative group, 11 (4 type-A, 5 type-B and 2
type-C) stents were placed in ten patients; one received
two stents. In all patients in whom stents were placed,
bowel preparation was successful and at the placement
site, the colon was clean. Surgery was performed 2 9
(mean, 5 2.07) days after stent insertion, and no compli-
cations, such as wound infection or abdominal abscess for-
mation, occurred (Fig. 2).
In the palliative group, 19 stents (4 type-A, 11 type-B, 4
type-C) were placed in 15 patients. The mean period of pa-
tency was 96.25 105.12 days: 146.25 112.93 for type-
A, 78.82 112.26 for type-B, and 94.25 84.21 for type-
C; the differences were statistically insignificant (p=0.576)
(Table 4). Six placements in five patients were clinically
unsuccessful: five involved stent migration and in one, the
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Table 3. Clinical Success of Stent Placement
Stent Type
Total
AB C
Total Placements 8 16 6 30
Successes 8 11 5 24
Percent (%) 100 68.8 83.3 80.0
p=0.191
Note. Chi-square test 
Fig. 2. Type-A stent placement for
presurgical bowel preparation (patient
#10).
A. Irregular narrowing of the proximal
rectum (arrow) is apparent.
B. Although focal narrowing remains,
good passage of contrast medium is ob-
served after type-A stent placement.
Four days after placement, this patient
underwent anastomosis and tumor re-
section.
AB
Table 4. Summary of Complications
Purpose Complication Mean Period of
No. of Stent Placements Patency in Palliative
Presurgical Palliative
Anal Pain (%) Bleeding (%) Stent Migration (%) Group (days)
Non-covered Type A 4 04 2 (25.0%) 0 0 146.25 112.93
Covered
Type B 5 11 1 (06.3%) 2 (12.5%) 6 (37.5%) 078.82 112.26
Type C 2 04 1 (16.7%) 3 (50%)0. 0 094.25 084.21
p value 0.429 0.037 0.038 0.576
Note. Chi-square test,    Kaplan Meier teststent failed to expand completely. In two patients (#1, 3),
two type-B stents were placed, but all four migrated within
1.3 0.5 (range, 1 2) days of placement. In one patient
(#1) bowel obstruction was relieved after the second mi-
gration, and the symptoms associated with obstruction did
not develop for seven months, at which point a T-loop
colostomy was performed. In patient #11, a type-A stent
was placed after a type-B migrated, and this led to the re-
lief of obstruction. In the remaining (#24), the type-C stent
used did not fully expand and a T-loop colostomy was per-
formed. At 180 and 79 days, respectively, after insertion,
two of the clinically improved patients (#8, 25) underwent
T-loop colostomy or ileostomy because of symptom recur-
rence due to tumor overgrowth (Fig. 3).
The overall complication rate was 50.0%: 50% for type
A, 56.3% for type B, and 33.3% for type C. The complica-
tions involved were migration (n=6, 20.0%), pain (n=4,
13.3%), minor bleeding (n=5, 16.7%), incomplete stent
expansion (n=1, 3.3%), and tumor ingrowth (n=1, 3.3%)
(Table 4). The migration rate was significantly higher in the
type-B group (p=0.038), while minor bleeding developed
frequently in the type-C group (p=0.037). Two of nine pa-
tients with primary rectal cancer and two of 12 with rec-
tosigmoid colon cancer complained of anal pain after stent
placement. Two in whom a type-A stent had been placed
complained of pain, which in one case was severe; those
who underwent type-B stent placement complained of pain
in one case, and minor bleeding in two. Type-C stents
caused pain in one case and minor bleeding in three, and in
one other there was incomplete expansion. Patient #1 un-
derwent emergency colostomy seven months after stent
migration. The type-B stent placed in patient #11 migrated
nine days after placement, and was replaced with a type-A
stent; relief from bowel obstruction lasted 27 days. In pa-
tients #21, in whom a type-A stent was inserted, obstruc-
tion recurred due to tumor ingrowth and was confirmed by
endoscopy. We placed an additional type-C stent inside the
type-A stent, and until her death, this patient experienced
no further bowel obstruction. (Fig. 4). In patient #23, who
underwent type-C stent insertion, another stricture was
discovered just below the stent. We removed this, using a
hook, replacing it with a type C, which was longer.
DISCUSSION
Malignant colonic tumors, which cause acute obstruction,
are often difficult to treat. They have traditionally required
emergency surgical decompression by colostomy, followed
by resection, a procedure that carries a high rate of mor-
bidity and mortality (7 9). Benign strictures occurring af-
ter radiation therapy, surgery (such as colostomy repair),
or end-to-end anastomosis of the large intestine increase
the difficulty of treatment, and the avoidance of a perma-
nent colostomy, by means of rectal conservation, is also an
important quality-of-life issue (5). For these reasons, the
use of minimally invasive treatment techniques that reduce
the need for, or supplement, surgery and emphasise quality
of life needs to be explored. 
The placement of an expandable metallic stent is an al-
ternative option for the treatment of acute colonic obstruc-
tion (7 12). The self-expanding stents currently available
have great elasticity, which allows them to flex along the
longitudinal axis and adapt to the angles of the intestinal
lumen. Moreover, they maintain their most recent form af-
ter being inserted across a stenosis, exercising only radial
pressure (10). Although a statistically significant benefit
arising from the use of the large 22-mm-diameter Wallstent
placed by Mainar et al. (5) has not, to our knowledge, been
Kang et al.
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Fig. 3. Type-B stent placement for pallia-
tion (patient #8).
A. Irregular narrowing of the rectosig-
moid colon (arrow) can be seen.
B. After type-B stent placement, good
patency is observed (arrow). In this pa-
tient, symptoms of obstruction recurred
180 days after placement, and a pallia-
tive ileostomy was performed.
ABproven, the use of a large-diameter self-expanding stent
may decrease the risk of stent dysfunction due to stool im-
paction or mucosal prolapse, particularly in cases involving
palliative placement. A new self-expanding metal stent
with an internal diameter of 24 to 30 mm might broaden
the clinical indications for this therapy (11). In our study,
covered stents with an internal diameter of 24-26 mm, and
non-covered, coated stents with an internal diameter of 30
mm were used. In the palliative group, symptoms of ob-
struction recurred in two of 14 clinically successful place-
ments, though in the remaining 12 such placements, pa-
tients were free of such symptoms until their death. For the
palliation of colonic obstruction, metallic stents of a larger
diameter were effective. Among the three types of stent,
differences in the mean period of patency were not statisti-
cally significant (p =0.576).
The complications reported after stent placement have
included stent migration, pain, bleeding, bowel perfora-
tion, tumor ingrowth, and new obstructions (7). In our
study, tumor ingrowth was confirmed by fluoroscopy in
one patient. We inserted an additional covered stent inside
the one which was non-covered, and the patient was sub-
sequently able to defecate well until her death. Minor
bleeding developed in five patients in the covered stent
group: because a larger introductory system is required,
the placement of such stents may be more traumatic.
Severe pain developed in one patient in the non-covered
stent group, and could not controlled by medication. We
Efficacy of Metallic Stent Placement in Treatment of Colorectal Obstruction
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Fig. 4. Type-C stent placement inside a
type-A stent (patient #21).
A. Tumor ingrowth, which developed four
months after stent placement, was con-
firmed by endoscopy.
B. Guidewire advanced through previ-
ously placed type-A stent.
C. Deployment of type-C stent (arrow),
which is longer than type A (arrow-
heads).
D. The type-C stent showed good paten-
cy and was patent for three months, until
the patient’s death.
AB
CDbelieve that in this case the stent should have been re-
moved, but once a non-covered stent is in position, this is
not easy. Because of continuous stress on a tumor, that can
give rise to stretching pain, the use of stents of a larger di-
ameter did tend to cause pain. In our study, the incidence
of this was highest when type-A stents were used, though
among different stent types the differences in this regard
were not statistically significant.
The HD50 of type-A, -B, and -C stents was 530, 690,
and 280 grams of force, respectively. In patient 24, who
underwent type-C stent insertion, conventional follow-up
radiography revealed incomplete stent expansion, and dur-
ing the eight-day follow-up period, at the end of which a T-
loop colostomy was performed, the patient produced only
a small amount of feces. In this case, the type-C stent
should have been removed, prior to the insertion of one
which was more powerful, such as the type B. In 24 in-
stances of clinically successful stent placement, convention-
al radiography or fluoroscopic examination demonstrated
that in each case, stent expansion was almost complete. All
three types of colorectal stents showed good longitudinal
flexibility and incorporated anti-migration features such as
flaring or shouldering. In our study, the type-C stent had a
lower migration rate than the type-B, and according to our
results, shouldering might be more effective than flaring. In
addition, a stent body constructed in such a way that gaps
between segments are small effectively minimizes migra-
tion and improves longitudinal flexibility.
The selection of stent type depended on tumor location
and size. A non-covered stent could be introduced as far as
the distal ascending colon, but because of its large and rigid
introductory catheter, placement of a covered stent proxi-
mal to the descending colon was difficult. A stent which is
covered can be safely positioned, and one which is retriev-
able can easily be repositioned or removed if a complica-
tion arises. In addition, spillage of the contents of a rup-
tured large bowel can be prevented (13 15).
This study suffers several limitations. First, patient selec-
tion was incompletely randomized and there might thus
have been a selection bias. Second, our study design was
less than fully appropriate. The migration rate of type-B
stents was higher than expected, but should have been pre-
evaluated by means of a pilot study. Finally, the number of
patients involved was too small to fully evaluate the statis-
tical significance of the findings.
In conclusion, newly designed self-expanding metallic
stents of a larger diameter (24 30 mm) were effective for
the palliation or preoperative decompression of obstructive
symptoms. Where covered stents with flaring were used,
the migration rate was higher. Differences in the mean pa-
tency period between the three types of stent were not sta-
tistically significant. For evaluation of the ideal stent con-
figuration for the treatment of colorectal obstruction, a
clinical study involving a larger group of patients is war-
ranted.
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